PHARMERICA CORPORATION (NYSE:PMC) Files An 8-K Results of Operations and Financial ConditionItem 2.02 Results of Operations and Financial Condition.
On August 2, 2017, PharMerica Corporation (the “Company”) issued a press release announcing results of operations for the second quarter ended June 30, 2017, a copy of which is attached as Exhibit 99.1.
Item 2.02 Financial Statements and Exhibits.
(d) Exhibits
| 99.1 | Press Release of PharMerica Corporation dated August 2, 2017. |
PharMerica CORP ExhibitEX-99.1 2 dp79130_ex9901.htm EXHIBIT 99.1 Exhibit 99.1 Contact: Robert E. Dries Executive Vice President and Chief Financial Officer (502) 627-7140 PHARMERICA REPORTS SECOND QUARTER 2017 RESULTS Separately Announced All-Cash Transaction with KKR and Walgreens Boots Alliance,…To view the full exhibit click here
About PHARMERICA CORPORATION (NYSE:PMC)
PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States. It has three segments: institutional pharmacy, specialty infusion services and specialty oncology pharmacy. Its institutional pharmacy segment provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings. Its specialty infusion services segment provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital. Its specialty oncology pharmacy segment provides dispensing of oncology drugs, care management and other related services.